Concepedia

Jessika Tourneur

JT

Statistics

Publications

3

Citations

64

H-Index

3

Active since

2021

Affiliations

Abivax (France)(Current)

Jessika Tourneur is an author at Abivax (France) specializing in vaccine development, egg-based vaccine production, and medicine.

Top concepts

Publications per year

2021–2023

3

Publications

3

Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine

Isabel Leroux‐Roels, Gwenn Waerlop, Jessika Tourneur et al. · Frontiers in Immunology · 2022 · 25 citations · Full text

Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trial

Isabel Leroux‐Roels, Paul Willems, Gwenn Waerlop et al. · The Lancet Infectious Diseases · 2023 · 22 citations · Full text

, , +11

Phase 1 Randomized, Placebo-Controlled, Dose-Escalating Study to Evaluate OVX836, a Nucleoprotein-Based Influenza Vaccine: Intramuscular Results

Kanchanamala Withanage, Ilse De Coster, Nathalie Cools et al. · The Journal of Infectious Diseases · 2021 · 17 citations · Full text

1–3 of 3